Understanding Results Declare Timi 58
Exploring Results Declare Timi 58 reveals several interesting facts. Stephen D. Wiviott, MD, principal investigator, summarizes the
Key Takeaways about Results Declare Timi 58
- Prof Itamar Raz (Hadassah Hebrew University Hospital, Jerusalem, IL) discuss
- Stephen Wiviott, MD, discusses a few of the strengths and limitations important for interpreting the
- DECLARE
- Dapagliflozin vs Placebo in cardiovascular and kidney outcomes.
- JAMAMedNews Eric D. Peterson, MD, MPH discusses the
Detailed Analysis of Results Declare Timi 58
Results Eric Peterson, MD, chair of the program committee for Scientific Sessions 2018, comments on the Prof Stephen D. Wiviott discusses the
Dr. Stephen Wiviott, Senior Investigator of the
Stay tuned for more updates related to Results Declare Timi 58.